PRESS RELEASE published on 10/01/2024 at 07:00, 1 year 7 months ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
BRIEF published on 05/15/2024 at 09:07, 2 years ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
BRIEF published on 05/15/2024 at 09:07, 2 years ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
PRESS RELEASE published on 05/15/2024 at 09:02, 2 years ago Inside Information / Other news releases Advicenne's Board of Directors' resolutions approved at the Combined General Meeting. Shareholders support all resolutions including financial statements and delegations Board Of Directors Shareholders Financial Statements Combined General Meeting Advicenne
BRIEF published on 05/15/2024 at 08:06, 2 years ago Advicenne launches a share buyback program Share Buyback Euronext Growth Financial Market Advicenne Kidney Diseases
BRIEF published on 05/15/2024 at 08:06, 2 years ago Advicenne lance un programme de rachat d'actions Marché Financier Rachat D'actions Euronext Growth Advicenne Maladies Rénales
PRESS RELEASE published on 05/15/2024 at 08:01, 2 years ago Informations privilégiées / Autres communiqués Advicenne annonce un programme de rachat d'actions autorisé par son assemblée générale mixte. Le programme permet l'achat de jusqu'à 10% du capital social avec un prix maximum de 21 euros par action Rachat D'actions Euronext Growth Programme Autorisation Advicenne
Published on 05/22/2026 at 08:00, 4 hours 16 minutes ago Caledonia Mining Corporation Plc: Refiling of Bilboes Gold Project Feasibility Study National Instrument 43-101 Technical Report
Published on 05/21/2026 at 23:00, 13 hours 16 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 13 hours 16 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 13 hours 16 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/22/2026 at 11:33, 43 minutes ago Project WAL reserves capacity on GASCADE’s H2 core network
Published on 05/22/2026 at 11:30, 46 minutes ago AppliedAI and McKinsey & Company collaborate to rapidly rewire regulated enterprise processes with AI
Published on 05/22/2026 at 11:05, 1 hour 11 minutes ago RITFIT Partners with LA Galaxy's Marco Reus, Redefining High Quality Training at Home and Showcasing the Evolution of Professional Home Gym Ecosystems
Published on 05/22/2026 at 11:05, 1 hour 11 minutes ago Hisense Introduces UR8 with Natural and Real Color, Bringing Next-Generation RGB MiniLED Technology to More Homes
Published on 05/22/2026 at 11:00, 1 hour 16 minutes ago EQS-Adhoc: Gothaer All2025 financial year: BarmeniaGothaer reports above-market growth and high profitabilitygemeine Versicherung AG:
Published on 05/22/2026 at 08:30, 3 hours 46 minutes ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/22/2026 at 08:30, 3 hours 46 minutes ago Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc
Published on 05/21/2026 at 17:45, 18 hours 31 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 18 hours 31 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
